產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
GC39514-10mg |
|
1801765-04-7 |
TNO155 - Glpbio |
0 | 需詢價(jià) | C18H24ClN7OS | |
GC39514-5mg |
|
1801765-04-7 |
TNO155 - Glpbio |
0 | 需詢價(jià) | C18H24ClN7OS | |
GC39513-500mg |
|
2093386-51-5 |
Thalidomide-NH-C6-NH2 TFA - Glpbio |
0 | 需詢價(jià) | C21H25F3N4O6 | |
GC39513-250mg |
|
2093386-51-5 |
Thalidomide-NH-C6-NH2 TFA - Glpbio |
0 | 需詢價(jià) | C21H25F3N4O6 | |
GC39513-100mg |
|
2093386-51-5 |
Thalidomide-NH-C6-NH2 TFA - Glpbio |
0 | 需詢價(jià) | C21H25F3N4O6 | |
GC39512-100mg |
|
2564-83-2 |
Tempo - Glpbio |
0 | 需詢價(jià) | C10H21NO? | |
GC39511-100mg |
|
— |
Synucleozid hydrochloride - Glpbio |
0 | 需詢價(jià) | C22H21ClN6 | |
GC39511-50mg |
|
— |
Synucleozid hydrochloride - Glpbio |
0 | 需詢價(jià) | C22H21ClN6 | |
GC39511-10mg |
|
— |
Synucleozid hydrochloride - Glpbio |
0 | 需詢價(jià) | C22H21ClN6 | |
GC39511-5mg |
|
— |
Synucleozid hydrochloride - Glpbio |
0 | 需詢價(jià) | C22H21ClN6 | |
GC39510-100mg |
|
502139-01-7 |
Synucleozid - Glpbio |
0 | 需詢價(jià) | C22H20N6 | |
GC39510-50mg |
|
502139-01-7 |
Synucleozid - Glpbio |
0 | 需詢價(jià) | C22H20N6 | |
GC39510-10mg |
|
502139-01-7 |
Synucleozid - Glpbio |
0 | 需詢價(jià) | C22H20N6 | |
GC39510-5mg |
|
502139-01-7 |
Synucleozid - Glpbio |
0 | 需詢價(jià) | C22H20N6 | |
GC39509-25mg |
|
148470-19-3 |
Substance P TFA - Glpbio |
0 | 需詢價(jià) | C63H98N18O13S.xC2HF3O2 | |
GC39509-10mg |
|
148470-19-3 |
Substance P TFA - Glpbio |
0 | 需詢價(jià) | C63H98N18O13S.xC2HF3O2 | |
GC39509-5mg |
|
148470-19-3 |
Substance P TFA - Glpbio |
0 | 需詢價(jià) | C63H98N18O13S.xC2HF3O2 | |
GC39509-1mg |
|
148470-19-3 |
Substance P TFA - Glpbio |
0 | 需詢價(jià) | C63H98N18O13S.xC2HF3O2 | |
GC39508-100mg |
|
2169919-21-3 |
SNDX-5613 - Glpbio |
0 | 需詢價(jià) | C32H47FN6O4S | |
GC39508-50mg |
|
2169919-21-3 |
SNDX-5613 - Glpbio |
0 | 需詢價(jià) | C32H47FN6O4S | |